Melanóma: vizsgálatok itt: Egyesült Államok
269 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleHepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis
- Where
- Madison
- Életkor
- 18 év and over
- People
- 15
- Run by
- University of Wisconsin, Madison
See details and how to joinNCT07281924 - No phaseTaking peopleClinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
- Where
- Bethesda
- Életkor
- 4 hét to 99 év
- People
- 3000
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT00040352 - No phaseTaking peopleCancer Experience Registry (CER) for Cancer Patients and Caregivers
- Where
- Washington D.C.
- Életkor
- 18 év and over
- People
- 15 000
- Run by
- Cancer Support Community, Research and Training Institute, Philadelphia
See details and how to joinNCT02333604 - 1/2. fázisTaking peopleAdministering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- Where
- Bethesda
- Életkor
- 18 év to 72 év
- People
- 124
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT02830724 - 2. fázisTaking peopleDB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- Where
- Anderson, Atlanta, Bethesda, Charleston, Florida City, Houston, Lincoln, Los Angeles, New York, Portland, Puyallup, Spokane, Virginia Beach, Wheat Ridge
- Életkor
- 18 év and over
- People
- 750 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT06953089 · EU 2025-523895-22-00 - 2. fázisNot yet taking people in Egyesült ÁllamokMirdametinib to Reduce the Size of Large/Giant Congenital Melanocytic Nevi in Children, Adolescents and Young Adults
- Where
- Bethesda
- Életkor
- 3 év to 40 év
- People
- 15
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07891286 - 2. fázisTaking peopleInterleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma
- Where
- Boston, Los Angeles, New York
- Életkor
- 18 év to 100 év
- People
- 105
- Run by
- NYU Langone Health
See details and how to joinNCT05428007 - 1. fázisTaking peopleA Study of MGC026 in Participants With Advanced Solid Tumors
- Where
- Grand Rapids, Houston, Lake Success, Los Angeles, Portland, West Valley City
- Életkor
- 18 év and over
- People
- 394 worldwide
- Run by
- MacroGenics
See details and how to joinNCT06242470 - No phaseCsak meghívásosTruScore Standalone Clinical Study
- Where
- Boston, Lutherville, Philadelphia, Pleasanton, Tampa, Walnut Creek
- Életkor
- 22 év and over
- People
- 464
- Run by
- VeriSkin, Inc.
See details and how to joinNCT06793423 - 1/2. fázisTaking peoplePhase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
- Where
- Boston, Nashville, Scottsdale
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- Strand Therapeutics Inc.
See details and how to joinNCT07751042 - No phaseCsak meghívásosCommunity Based Strategies for Early Detection of Melanoma
- Where
- Los Angeles
- Életkor
- 18 év and over
- People
- 200
- Run by
- Cedars-Sinai Medical Center
See details and how to joinNCT04799106 - 1/2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Amarillo, Chattanooga, Dallas, Fairfax, Germantown, Los Angeles, Minneapolis, Nashville, New York, Pearland, Salt Lake City, Skokie, Wenatchee, Westbury, White Plains, Whittier
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - 1. fázisTaking peopleMemory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors
- Where
- St Louis
- Életkor
- 18 év and over
- People
- 33
- Run by
- Washington University School of Medicine
See details and how to joinNCT05629546 - No phaseTaking peopleImmune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver
- Where
- Boston
- Életkor
- 18 év and over
- People
- 20
- Run by
- Massachusetts General Hospital
See details and how to joinNCT07364474 - 3. fázisTaking peopleThe Cancer of the Pancreas Screening-5 CAPS5)Study
- Where
- Ann Arbor, Baltimore, Boston, Cleveland, New Haven, New York, Philadelphia, Pittsburgh
- Életkor
- 18 év and over
- People
- 9000
- Run by
- Johns Hopkins University
See details and how to joinNCT02000089 - 1/2. fázisTaking peopleStudy of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
- Where
- Austin, Cincinnati, Dallas, Detroit, Englewood, Fairfax, Fairway, Houston, La Jolla, Lake Success, Laredo, Los Angeles, Madison, Maple Grove, Nashville, Rochester, San Francisco, Tucson
- Életkor
- 18 év and over
- People
- 92
- Run by
- Aminex Therapeutics, Inc.
See details and how to joinNCT07287917 - 3. fázisTaking peopleUsing an Artificial Intelligence (AI) Tool for Melanoma Diagnosis
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Stanford, Uniondale
- Életkor
- 18 év and over
- People
- 14 000
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07890415 - 1/2. fázisTaking peopleA Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Where
- Atlanta, Austin, Canton, Celebration, Charleston, Cincinnati, Dallas, Dayton, Detroit, Fairfax, Greenville, Las Vegas, Los Angeles, Louisville, Margate, Nashville, New York, Orlando, Plantation, Saint Paul, Santa Monica, Spokane, Tamarac, Tucson
- Életkor
- 18 év and over
- People
- 862 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05914116 - 1/2. fázisTaking peopleIntratumoral N17350 in Advanced Solid Tumors
- Where
- Buffalo, Houston, Los Angeles, San Diego, San Francisco
- Életkor
- 18 év and over
- People
- 275 worldwide
- Run by
- Onchilles Pharma Inc
See details and how to joinNCT07339176 - 1/2. fázisTaking peopleAxelopran and Nivolumab in PD-1-Refractory Metastatic Melanoma
- Where
- Pittsburgh
- Életkor
- 18 év and over
- People
- 28
- Run by
- John Kirkwood
See details and how to joinNCT07631325 - No phaseTaking peopleFrequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
- Where
- Columbus
- People
- 500
- Run by
- Mohamed Abdel-Rahman
See details and how to joinNCT04792463 - No phaseCsak meghívásosProspective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
- Where
- Bethesda
- Életkor
- 18 év and over
- People
- 1200
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05600933 - No phaseNot yet taking people in Egyesült ÁllamokPersonalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial
- Where
- Ann Arbor
- Életkor
- 20 év to 39 év
- People
- 142
- Run by
- University of Michigan Rogel Cancer Center
See details and how to joinNCT07529080 - 1/2. fázisTaking peopleImmunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
- Where
- Atlanta, Aventura, Baltimore, Chicago, City of Saint Peters, Coral Gables, Creve Coeur, Deerfield Beach, La Jolla, Lexington, Los Angeles, Miami, Mineola, New York, North Miami, Pittsburgh, Plantation, Salt Lake City, Shiloh, St Louis, Washington D.C.
- Életkor
- 18 év and over
- People
- 16
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05896839 - 1/2. fázisTaking peopleMC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
- Where
- Chapel Hill, Cleveland, Iowa City, Jacksonville, Lexington, Madison, Miami, Minneapolis, Omaha, Orange, Philadelphia, Pittsburgh, Rochester, Sarasota, St Louis
- Életkor
- 18 év to 90 év
- People
- 300
- Run by
- Perspective Therapeutics
See details and how to joinNCT05655312